This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Universitè De Genève. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Marieke Veurink: Innovator in Monoclonal Antibody Formulations
Introduction
Marieke Veurink is a prominent inventor based in Geneva, Switzerland. She has made significant contributions to the field of biomedical research, particularly in the development of innovative formulations for monoclonal antibodies.
Latest Patents
Marieke holds a patent for "Bevacizumab formulations with lower aggregation propensity, comprising corticosteroid anti-inflammatory drugs." This invention focuses on combination formulations of monoclonal antibodies with anti-inflammatory agents, along with related methods and uses.
Career Highlights
Marieke is affiliated with the University of Geneva, where she conducts her research and development work. Her expertise in the field has led to advancements that enhance the efficacy and stability of therapeutic agents.
Collaborations
She has collaborated with notable colleagues, including Robert Gurny and Cinzia Stella, to further her research initiatives and explore new avenues in biomedical innovation.
Conclusion
Marieke Veurink's work exemplifies the intersection of innovation and healthcare, showcasing her commitment to improving therapeutic formulations. Her contributions are paving the way for advancements in the treatment of various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile